William Usinger
10Patents
3h-index
18Co-inventors
57Inventor score
Filing activity: Sep 1, 1989 → Mar 20, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4978622A | Cytophaga-derived immunopotentiator | Human Necessities | 117 | Expired |
| US7405274B2 | Connective tissue growth factor antibodies | Chemistry; Metallurgy | 23 | Expired |
| US7871617B2 | Antibodies that bind to a portion of the VWC domain of connective tissue growth factor | Chemistry; Metallurgy | 5 | Active |
| US9017668B2 | High affinity human antibodies to human cytomegalovirus (CMV) gB protein | Chemistry; Metallurgy | 1 | Active |
| US10030069B2 | High affinity human antibodies to human cytomegalovirus (CMV) gB protein | Chemistry; Metallurgy | 0 | Active |
| US9688744B2 | High affinity human antibodies to human cytomegalovirus (CMV) GB protein | Chemistry; Metallurgy | 0 | Active |
| US9034643B2 | Connective tissue growth factor antibodies | Chemistry; Metallurgy | 0 | Active |
| US10676520B2 | Antibodies useful in passive influenza immunization | Chemistry; Metallurgy | 0 | Active |
| US10654915B2 | Antibodies useful in passive influenza immunization | Chemistry; Metallurgy | 0 | Active |
| US8314059B2 | Diabetic nephropathy therapies | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.